Literature DB >> 31882497

Advanced Age Is a Risk Factor for Recurrence After Resection in Stage II Colorectal Cancer.

Kosuke Mima1, Junji Kurashige2, Nobutomo Miyanari2, Atsushi Morito2, Shinsei Yumoto2, Takashi Matsumoto2, Keisuke Kosumi2, Mitsuhiro Inoue2, Takao Mizumoto2, Tatsuo Kubota2, Hideo Baba3.   

Abstract

BACKGROUND/AIM: The number of older patients with colorectal cancer (CRC) is increasing. Stage II CRC is a heterogeneous group of cancers with different prognoses. We aimed to examine older patients in relation to clinical outcome following curative resection in stage II CRC. PATIENTS AND METHODS: We analyzed data for 329 consecutive patients with stage II CRC following curative resection. Recurrence-free survival (RFS) and overall survival (OS) were compared between older patients ≥75 years of age and those <75 years. Cox proportional hazards model was used to compute hazard ratios (HRs) controlling for potential confounders.
RESULTS: In the multivariable analyses, patients ≥75 years were independently associated with shorter RFS (multivariable HR=2.56, 95% confidence interval (CI)=1.55-4.31, p<0.001) and OS (multivariable HR=4.36, 95%CI=2.08-9.97, p<0.001) in stage II CRC.
CONCLUSION: Older patients were independently associated with shorter RFS and OS following curative resection in stage II CRC. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Carcinoma; geriatrics; gerontology; morbidity; mortality

Mesh:

Year:  2020        PMID: 31882497      PMCID: PMC6984108          DOI: 10.21873/invivo.11779

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  51 in total

1.  Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer.

Authors:  Marco Braga; Luca Gianotti; Andrea Vignali; Valerio Di Carlo
Journal:  Surgery       Date:  2002-11       Impact factor: 3.982

2.  Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  R Labianca; B Nordlinger; G D Beretta; S Mosconi; M Mandalà; A Cervantes; D Arnold
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

3.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

4.  Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10.

Authors:  Dirk L Kienle; Daniel Dietrich; Karin Ribi; Andreas Wicki; Luca Quagliata; Ralph C Winterhalder; Dieter Koeberle; Daniel Horber; Sara Bastian; Marc Kueng; Piercarlo Saletti; Daniel Helbling; Daniela Baertschi; Alessandro Lugli; Juerg Bernhard; Christiane Andrieu; Roger von Moos
Journal:  J Geriatr Oncol       Date:  2018-12-14       Impact factor: 3.599

5.  Prognostic value of CA 19.9 levels in colorectal cancer.

Authors:  X Filella; R Molina; J J Grau; J M Piqué; J C Garcia-Valdecasas; E Astudillo; A Biete; J M Bordas; A Novell; E Campo
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

6.  Clinical Usefulness of Perioperative C-reactive Protein/Albumin Ratio in Patients With Intrahepatic Cholangiocarcinoma: A Retrospective Single Institutional Study.

Authors:  Yosuke Nakao; Yo-Ichi Yamashita; Kota Arima; Tatsunori Miyata; Rumi Itoyama; Toshihiko Yusa; Naoki Umezaki; Takanobu Yamao; Shigeki Nakagawa; Hirohisa Okabe; Katsunori Imai; Akira Chikamoto; Hideo Baba
Journal:  Anticancer Res       Date:  2019-05       Impact factor: 2.480

7.  Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT database.

Authors:  Qian Shi; Thierry Andre; Axel Grothey; Greg Yothers; Stanley R Hamilton; Brian M Bot; Daniel G Haller; Eric Van Cutsem; Chris Twelves; Jacqueline K Benedetti; Michael J O'Connell; Daniel J Sargent
Journal:  J Clin Oncol       Date:  2013-08-26       Impact factor: 44.544

8.  Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer.

Authors:  Kazuo Okadome; Yoshifumi Baba; Taisuke Yagi; Yuki Kiyozumi; Takatsugu Ishimoto; Masaaki Iwatsuki; Yuji Miyamoto; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  Ann Surg       Date:  2020-04       Impact factor: 12.969

Review 9.  Aging, Cancer and Immunity.

Authors:  Hong Hong; Qi Wang; Jing Li; Hans Liu; Xin Meng; Haiyan Zhang
Journal:  J Cancer       Date:  2019-06-02       Impact factor: 4.207

Review 10.  Treatment of Elderly Patients with Colorectal Cancer.

Authors:  Yoshiro Itatani; Kenji Kawada; Yoshiharu Sakai
Journal:  Biomed Res Int       Date:  2018-03-11       Impact factor: 3.411

View more
  1 in total

1.  A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling.

Authors:  Po-Chuan Chen; Yu-Min Yeh; Bo-Wen Lin; Ren-Hao Chan; Pei-Fang Su; Yi-Chia Liu; Chung-Ta Lee; Shang-Hung Chen; Peng-Chan Lin
Journal:  Biomedicines       Date:  2022-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.